News
GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…
GADx formed to expand affordable access to advanced rapid diagnostic technologies
Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…
Mologic partners with FINDdx for schistosomiasis rapid test
Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and…
Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…
Cystatin C test: Developing a rapid test to allow users to track kidney function
Working with Bloom Diagnostics, Global Access Diagnostics (GADx) developed a Kidney Test to measure cystatin C level, a well-established indicator of kidney function. What is CKD? Kidneys play a vital role in filtering blood; removing…
Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors
A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch of Global Access Health (GAH), a…